Clinical Information for Innovative PGx and Infectious Disease Testing

Innovative Genomics offers a comprehensive menu of tests for a wide range of PGx, infectious disease (including COVID-19), and the list is constantly expanding as we proceed through additional research and approvals.

Testing Panels
Offered by Innovative Genomics

We offer the largest selection of DNA screening for prescribing medicine (over 60 genetic sequences and over 200 gene variants) in the treatment areas of:

Quality and dependable service for all our testing panels with quick results.

Start personalized medicine today for better health tomorrow!

Respi GxTM utilizes quantitative Real-Time Polymerase
Chain Reaction (qPCR) to rapidly analyze your
patient’s sample in 24 hours. RT-PCR technology
precisely detects the correct pathogens(s) and
identifies antibiotic drug resistance. This allows
providers the ability to prescribe timely and effective
treatment.

Respi GxTM utilizes quantitative Real-Time Polymerase Chain Reaction (qPCR) to rapidly analyze your patient’s sample in 24 hours. RT-PCR technology precisely detects the correct pathogens(s) and identifies antibiotic drug resistance. This allows providers the ability to prescribe timely and effective treatment.

Rapid and accurate solution eliminates guesswork in diagnosing and treating upper respiratory infections

Acute respiratory infection is a significant cause of morbidity and mortality in young, geriatric and immunocompromised patients. Co-infection is also high within these populations and access to advanced technology is essential to detect multiple pathogens at once. False negative test results can lead to a delayed diagnosis and poor clinical outcomes.

Respi GxTM quickly identifies pathogens and detects potential antibiotic resistance, so effective treatment can begin sooner.

Accurate diagnosis within 24 hours with real-time PCR for pathogen identification and detection of antibiotic resistance

Helps improve clinical confidence and decrease patient risks